None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) 19 years of age or older 2) In case of histological diagnosis of amyloidosis 3) If you voluntarily agree to participate in the study
Exclusion criteria
Exclusion criteria: 1) In case of uncontrolled severe disease other than multiple myeloma 2) Decompensated heart failure inability to lie down immediately for 1 hour 3) Severe claustrophobia that does not improve even with the use of sedatives 4) Pregnant or lactating women 5) Serious liver disease 6) History of epilepsy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In patients with amyloidosis, dynamic changes in the degree of amyloid deposition are checked using amyloid PET/CT images before and after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the cardiac function of patients with amyloidosis and the degree of cardiac involvement on amyloid PET/CT.;Diagnosis of organ involvement in amyloid PET/CT in patients with amyloidosis, and evaluation of correlation with hematologic disease markers and other imaging test results.;To evaluate the association of amyloid PET/CT with haematological and affected organ responses after treatment of amyloidosis patients. To evaluate the potential of amyloid PET/CT as a therapeutic response evaluation tool.;To evaluate the potential of amyloid PET/CT as a predictive tool for post-treatment response and survival in patients with amyloidosis.;To evaluate the possibility of amyloid PET/CT as a tool to predict multiple myeloma-associated amyloidosis in patients with multiple myeloma.;To compare and evaluate the cognitive function test results of patients with amyloidosis and the degree of brain amyloid deposition on amyloid PET/CT. | — |
Countries
Korea, Republic of
Contacts
The Catholic University of Korea, Seoul St. Mary's Hospital